|
|
|
SENSEX
|
|
486.50
|
0.66%
|
74339.44
|
|
|
NIFTY
|
|
167.95
|
0.75%
|
22570.35
|
|
|
Nasdaq
|
|
16.11
|
0.10%
|
15712.75
|
|
|
Nikkei 225
|
|
907.92
|
2.42%
|
38460.08
|
|
|
FTSE 100
|
|
-4.43
|
-0.06%
|
8040.38
|
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Lupin |
BSE Code |
500257
|
ISIN Demat |
INE326A01037
|
Book Value (Rs) |
443.07
|
|
NSE Code |
LUPIN
|
Dividend Yield % |
0.25
|
Market Cap (Rs) |
724232.49
|
|
TTM PE(x) |
35.14
|
TTM EPS(Rs) |
45.22
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
Incorporation Year
|
01-03 1983
|
Registered Office
|
Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East), Mumbai, Maharashtra-400055 .
|
ISINNO
|
INE326A01037
|
Phone
|
022 66402323
|
E-mail
|
info@lupin.com |
URL
|
www.lupin.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Manju D Gupta
|
Managing Director
|
Nilesh Gupta
|
Company Secretary
|
R V Satam
|
Listing
|
BSE,NSE,MCX
|
|
|
|
|
|
|
|
|
|
|
|